Delivery Order SPE2DU25D4211-SPE2DU26FB809
- Not listed
- The Defense Logistics Agency awarded a $85,563.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded contract, with no set-aside designation, is scheduled for completion on October 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,053.16 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on December 8, 2025, with an ultimate completion date of the same day, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) Medical Supply Chain has awarded a delivery order valued at $42,120.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price contract, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured...
- The Defense Logistics Agency has awarded a delivery order contract valued at $10,793.06 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on December 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $26,087.82 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 19, 2025, was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,740 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 18, 2025, with completion scheduled for June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive...
- The Defense Logistics Agency awarded a delivery order valued at $19,406.27 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 1, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set-aside and was competitively awarded through open...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $28,488.84 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $179,628.39 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside...
- SPE2DU25D4211Indefinite Delivery Contract
- SPE2DU25D4211-SPE2DU26FB809Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $121,332.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 24, 2025, with completion targeted for the same date, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order carries no set-aside designation, indicating it was competitively awarded through open procurement channels. Performance will take place at the contractor's Conshohocken facility. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical supply agreement with the DLA, which serves as a prime vendor vehicle supporting military healthcare systems and related federal medical procurement needs. AmerisourceBergen maintains a significant $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical running through December 2026, enabling the company to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and medical devices—to support global military healthcare programs. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across diverse therapeutic domains and transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $121.3k | 11/23/25 |